2025-04-01 2026-03-31 2026-03-31 false 06821964 WY Holdings Limited 64209Activities of other holding companies not elsewhere classified iso4217:GBP xbrli:pure 068219642025-04-01 068219642026-03-31 068219642025-04-01 2026-03-31 06821964bus:SmallEntities2025-04-01 2026-03-31 06821964bus:AuditExempt-NoAccountantsReport2025-04-01 2026-03-31 06821964bus:FullAccounts2025-04-01 2026-03-31 06821964core:WithinOneYear2026-03-31 06821964core:AfterOneYear2026-03-31 06821964core:WithinOneYear2025-04-01 2026-03-31 06821964core:AfterOneYear2025-04-01 2026-03-31 06821964core:CurrentFinancialInstruments2026-03-31 06821964core:Non-currentFinancialInstruments2026-03-31 06821964core:CurrentFinancialInstruments2025-04-01 2026-03-31 06821964core:Non-currentFinancialInstruments2025-04-01 2026-03-31 06821964core:LandBuildings2025-04-01 2026-03-31 06821964core:FurnitureFittings2025-04-01 2026-03-31 06821964core:OfficeEquipment2025-04-01 2026-03-31 06821964core:Vehicles2025-04-01 2026-03-31 06821964core:PlantMachinery2025-04-01 2026-03-31 06821964core:OtherPropertyPlantEquipment2025-04-01 2026-03-31 06821964core:LandBuildings2026-03-31 06821964core:PlantMachinery2026-03-31 06821964core:Vehicles2026-03-31 06821964core:FurnitureFittings2026-03-31 06821964core:OfficeEquipment2026-03-31 06821964core:OtherPropertyPlantEquipment2026-03-31 06821964core:Right-of-useAssets2025-04-01 2026-03-31 06821964core:Right-of-useAssets2026-03-31 06821964core:Goodwill2025-04-01 2026-03-31 06821964core:PatentsTrademarksLicencesConcessionsSimilar2025-04-01 2026-03-31 06821964core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-04-01 2026-03-31 06821964core:OtherResidualIntangibleAssets2025-04-01 2026-03-31 06821964core:Goodwill2026-03-31 06821964core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-03-31 06821964core:PatentsTrademarksLicencesConcessionsSimilar2026-03-31 06821964core:OtherResidualIntangibleAssets2026-03-31 06821964dpl:CostSales2025-04-01 2026-03-31 06821964dpl:AdministrativeExpenses2025-04-01 2026-03-31 06821964dpl:DistributionCosts2025-04-01 2026-03-3106821964core:ShareCapital2026-03-31 06821964core:SharePremium2026-03-31 06821964core:RevaluationReserve2026-03-31 06821964core:OtherReservesSubtotal2026-03-31 06821964core:ShareCapitalPreferenceShares2026-03-31 06821964core:CapitalRedemptionReserve2026-03-31 06821964core:OtherCapitalReserve2026-03-31 06821964core:RetainedEarningsAccumulatedLosses2026-03-3106821964core:ShareCapital2025-04-01 2026-03-31 06821964core:SharePremium2025-04-01 2026-03-31 06821964core:RevaluationReserve2025-04-01 2026-03-31 06821964core:OtherReservesSubtotal2025-04-01 2026-03-31 06821964core:RetainedEarningsAccumulatedLosses2025-04-01 2026-03-310682196412025-04-01 2026-03-31 0682196422025-04-01 2026-03-3106821964core:ShareCapital12025-04-01 2026-03-31 06821964core:ShareCapital22025-04-01 2026-03-3106821964core:SharePremium12025-04-01 2026-03-31 06821964core:SharePremium22025-04-01 2026-03-3106821964core:RevaluationReserve12025-04-01 2026-03-31 06821964core:RevaluationReserve22025-04-01 2026-03-3106821964core:RetainedEarningsAccumulatedLosses12025-04-01 2026-03-31 06821964core:RetainedEarningsAccumulatedLosses22025-04-01 2026-03-310682196412025-04-01 2026-03-3106821964core:Non-currentFinancialInstrumentscore:CostValuation2025-04-01 06821964core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-31 06821964core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-31 06821964core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-31 06821964core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2026-03-31 06821964core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3106821964core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-04-01 06821964core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-31 06821964core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-31 06821964core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-31 06821964core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2026-03-31 06821964core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-31 06821964core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2026-03-3106821964core:Non-currentFinancialInstruments2026-03-31 06821964core:Non-currentFinancialInstruments2025-03-31068219642024-04-01 068219642025-03-31 068219642024-04-01 2025-03-31 06821964core:WithinOneYear2025-03-31 06821964core:AfterOneYear2025-03-31 06821964core:CurrentFinancialInstruments2025-03-31 06821964core:Non-currentFinancialInstruments2025-03-31 06821964core:LandBuildings2025-03-31 06821964core:PlantMachinery2025-03-31 06821964core:Vehicles2025-03-31 06821964core:FurnitureFittings2025-03-31 06821964core:OfficeEquipment2025-03-31 06821964core:OtherPropertyPlantEquipment2025-03-31 06821964core:Right-of-useAssets2025-03-31 06821964core:Goodwill2025-03-31 06821964core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-03-31 06821964core:PatentsTrademarksLicencesConcessionsSimilar2025-03-31 06821964core:OtherResidualIntangibleAssets2025-03-31 06821964dpl:AdministrativeExpenses2024-04-01 2025-03-3106821964core:ShareCapital2025-03-31 06821964core:SharePremium2025-03-31 06821964core:RevaluationReserve2025-03-31 06821964core:OtherReservesSubtotal2025-03-31 06821964core:ShareCapitalPreferenceShares2025-03-31 06821964core:CapitalRedemptionReserve2025-03-31 06821964core:OtherCapitalReserve2025-03-31 06821964core:RetainedEarningsAccumulatedLosses2025-03-3106821964core:RetainedEarningsAccumulatedLosses2024-04-01 06821964core:ShareCapital2024-04-01 06821964core:SharePremium2024-04-01 06821964core:RevaluationReserve2024-04-01 06821964core:ShareCapital2024-04-01 2025-03-31 06821964core:SharePremium2024-04-01 2025-03-31 06821964core:RevaluationReserve2024-04-01 2025-03-31 06821964core:OtherReservesSubtotal2024-04-01 2025-03-31 06821964core:RetainedEarningsAccumulatedLosses2024-04-01 2025-03-310682196412024-04-01 2025-03-31 0682196422024-04-01 2025-03-3106821964core:ShareCapital12024-04-01 2025-03-31 06821964core:ShareCapital22024-04-01 2025-03-3106821964core:SharePremium12024-04-01 2025-03-31 06821964core:SharePremium22024-04-01 2025-03-3106821964core:RevaluationReserve12024-04-01 2025-03-31 06821964core:RevaluationReserve22024-04-01 2025-03-3106821964core:RetainedEarningsAccumulatedLosses12024-04-01 2025-03-31 06821964core:RetainedEarningsAccumulatedLosses22024-04-01 2025-03-3106821964bus:Director12025-04-01 2026-03-3106821964bus:Director22025-04-01 2026-03-3106821964bus:PrivateLimitedCompanyLtd2025-04-01 2026-03-31
WY Holdings Limited
Unaudited Financial Statements
for the year ended 31 March 2026
Company registration number 06821964
(England and Wales)

Company Information

For the year ended 31 March 2026
Directors C S Orchard
C J Grafham

Registered office 270 Kings Road
London
SW3 5AW

Registered number 06821964

Accountant UHY Hacker Young Fitch
Suite 2.06
Custom House
Custom House Square
Belfast
Northern Ireland
BT1 3ET

Statement of Financial Position

As at 31 March 2026
Notes
2026
2025
£
£
£
£
Fixed assets
Tangible assets
4
50,629
59,755
Investments
5
125
125
50,754
59,880
Current assets
Debtors
652,164
1,187,596
Cash at bank and in hand
358,757
197,182
1,010,921
1,384,778
Creditors
Amounts falling due within one year
6
(515,487)
(685,370)
(515,487)
(685,370)
Net current assets (liabilities)
495,434
699,408
Total assets less current liabilities
546,188
759,288
Net assets (liabilities)
546,188
759,288
Capital and reserves
Called up share capital
125
125
Profit and loss account
546,063
759,163
Total equity
546,188
759,288

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 16 July 2026 and are signed on its behalf by:

C J Grafham
C J Grafham
Director

Company registration number 06821964

Notes to the Financial Statements

For the year ended 31 March 2026

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.


Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2.3. Employee benefits

Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.

2.4. Foreign currencies

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

2.5. Tangible fixed assets and depreciation

All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Rate
Method
%
Plant and machinery
15
Straight-line
Fixtures and fittings
15
Straight-line

2.6. Investments

Investments in subsidiaries, associates, and joint ventures are measured at cost less any accumulated impairment losses. Other investments in equity instruments that are publicly traded are measured at fair value, with changes in fair value recognised in the income statement. Other investments in equity instruments that are not publicly traded are measured at fair value unless this cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses.

2.7. Financial instruments

Election and recognition

The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.


Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.


Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss.


If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.


Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.


Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.


Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

3. Employees

The average number of employees during the year was 2 (2025: 2).

4. Tangible fixed assets

Plant and machinery
Fixtures and fittings
Total
£
£
£
Cost
At 1 April 2025
6,769
54,073
60,842
At 31 March 2026
6,769
54,073
60,842
Depreciation and impairment
At 1 April 2025
85
1,002
1,087
Charge for the period
1,015
8,111
9,126
At 31 March 2026
1,100
9,113
10,213
Net book value
At 31 March 2026
5,669
44,960
50,629
At 31 March 2025
6,684
53,071
59,755

5. Fixed asset investments

Other investments
Total
£
£
Cost
At 1 April 2025
125
125
At 31 March 2026
125
125
Impairment
At 31 March 2026
-
-
Net book value
At 31 March 2026
125
125
At 31 March 2025
125
125

6. Creditors due within one year

2026
2025
£
£
Trade creditors
100,856
128,555
Other creditors
374,800
-
Directors loan account
20,000
-
Taxation and social security
14,206
1,415
Accruals and deferred income
5,625
555,400
Total
515,487
685,370

Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

7. Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £25,988 (2025 - £25,988).

There were no contributions payable to the fund at the balance sheet date.

8. Related party transactions

During the year the Company entered into transactions, in the ordinary course of business with related parties.


Transactions and balances

At 31 March 2026, the following balances were outstanding:

  • Amounts owed to the Company by subsidiary companies amounted to £440,510 (2025: £958,077).
  • Amounts owed by the Company to subsidiary companies amounted to £nil (2025: £34,001).


During the year, the Company wrote off £235,000 (2025: £nil) of an inter-company loan due from a subsidiary company.

During the year, the Company made purchases of £5,160 (2025: £46,600) from entities controlled by key management personnel.


At 31 March 2026:

  • Amounts owed to the Company by entities controlled by key management personnel were £nil (2025: £200).
  • Amounts owed by the Company to entities controlled by key management personnel were £475,545 (2025: £94,553).


Terms and conditions of transactions with related parties

Sales and purchases between related parties are conducted on normal market terms. Outstanding balances are unsecured, interest-free and are expected to be settled in cash within 60 days of the invoice date.

The Company has neither provided nor received any guarantees in respect of related party receivables or payables.

During the year ended 31 March 2026, the Company made no provision for doubtful debts relating to amounts owed by related parties (2025: £nil).


Key management personnel

Key management personnel comprise all directors who have authority and responsibility for planning, directing and controlling the activities of the Company.

Total remuneration, including dividends paid to these individuals, amounted to £170,232 during the year (2025: £181,438).

9. Controlling party

The ultimate controlling party for the year ended 31 March 2026 was Mr C S Orchard by virtue of his shareholdings in the company.